|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 91 No. 7 (April 1), 1998:
pp. 2573-2580
Decay-Accelerating Factor (CD55) and Membrane Inhibitor of Reactive
Lysis (CD59) Are Released Within Exosomes During In Vitro
Maturation of Reticulocytes
By
Herisoa Rabesandratana,
Jean-Pierre Toutant,
Hubert Reggio, and
Michel Vidal
From the Hôpital St Eloi, Laboratoire Central
d'hématologie; INRA, Physiologie Animale; and UMR 5539, Université Montpellier II, Montpellier, France.
 |
ABSTRACT |
Exosomes are membrane vesicles released by reticulocytes during
their maturation into erythrocytes. They have a clearing function because of their enrichment with some proteins known to decrease or
disappear from the cell surface during maturation, eg,
acetylcholinesterase (AChE) and transferrin receptor (TfR),
respectively. To better understand the molecular events leading to
protein sorting in exosomes, we analyzed the expression of
glycosylphosphatidylinositol (GPI)-anchored proteins on the exosome
surface through a technique involving bead coupling and flow cytometry
immunodetection. The presence of AChE, decay-accelerating factor (DAF),
membrane inhibitor of reactive lysis (MIRL), and lymphocyte
function-associated antigen 3 (LFA-3) on the surface of exosomes
obtained from normal and paroxysmal nocturnal hemoglobinuria (PNH)
reticulocytes, suggests that (1) the GPI anchor is efficiently sorted
during exosome formation, (2) exosome release could account for the
observed discrepancy in GPI-protein expression between reticulocytes
and erythrocytes from PNH patients, and (3) exosomes could have another
physiologic function related to controlling membrane attack complex
formation.
| |
INTRODUCTION |
DURING RETICULOCYTE maturation, some
membrane activities are lost through their release in the extracellular
medium, as they are associated with small lipid vesicles called
exosomes. The major membrane protein lost by this physiologic process
is the transferrin receptor (TfR), which completely disappears from the red blood cell (RBC) surface during
maturation.1 Other membrane proteins such as
acetylcholinesterase (AChE) and transporters of nucleosides, glucose,
and amino acids have been shown to be sorted in exosomes.1
The signals involved in this sorting process are still unknown.
Nevertheless, we recently showed that antibody-induced molecule
clustering increases TfR and AChE release within exosomes,2 suggesting that the aggregation of some membrane constituents may be
involved in this physiologic process. Different forms of AChE have been
described for various cells. RBC AChE was shown to be membrane-bound
through a glycosylphosphatidylinositol (GPI) anchor.3,4
AChE detected in exosomes therefore probably does not span the
membrane, excluding a direct interaction with a cytosolic protein (eg,
hsc 70) suggested to be involved in TfR sorting.5 On the
other hand, GPI-anchored proteins are known to be sorted into specific
lipid domains in different cell compartments such as the trans-Golgi
network or caveolae.6,7 Glycosphingolipids such as the
ganglioside GM1 were shown to be enriched in these lipid
domains.8
Other GPI-anchored proteins are present on the surface of RBCs. These
include the decay-accelerating factor (DAF, CD55) and membrane
inhibitor of reactive lysis (MIRL, CD59), two proteins that inhibit
formation of the membrane attack complex on autologous cell
surfaces.9,10
In hematologic disorder, paroxysmal nocturnal hemoglobinuria (PNH),
impaired transfer of N-acetylglucosamine to phosphatidylinositol leads
to a synthetic defect in GPI and thus to a deficiency in the surface
expression of all GPI-anchored proteins.11 Analysis of many
patients with PNH has shown that somatic mutation in the X-linked gene
PIG-A is responsible for the GPI-anchor deficiency in
PNH.12 Blood cells of PNH patients are affected
differently,13,14 but are generally more susceptible to
complement-mediated attack. Hemolysis of RBCs is the major clinical
indication of the disease, although the lack of DAF and/or MIRL
on the cell surface can vary markedly between patients. Moreover, there
is often a difference in the extent of erythrocytes and reticulocytes
affected in the RBC population.15
In the present study, we showed that the GPI-anchored proteins AChE,
DAF, MIRL, and LFA-3 were released in exosomes by reticulocyte during
in vitro maturation into erythrocytes. The extent of GPI-anchored proteins released within exosomes was not highly modified when reticulocytes of PNH patients were matured in vitro, indicating that
the GPI-anchor was efficiently sorted during vesicle formation. Exosome
release could thus account for the observed discrepancy in GPI-protein
expression between reticulocytes and erythrocytes from PNH
patients.15 Moreover, the presence of DAF and MIRL within
the exosomal membrane could provide vesicles released in the blood
circulation with another physiologic function related to the regulation
of membrane attack complex formation.
| |
MATERIALS AND METHODS |
Donors.
The two patients with PNH had marked deficiencies of CD55 and CD59
antigens. In particular, the presence of partially CD59 deficient (type
II) and completely deficient (type III) RBCs was detected for case 1 (see Fig 5). The reticulocyte count was determined by flow cytometric
analysis with thiazole orange labeling of RNA. Controls involved
patients with a high percentage of reticulocytes (always >6%) due to
other pathologic states, such as hemolytic anemia.
View larger version (31K):
[in this window]
[in a new window]
| Fig 5.
Surface expression of DAF and MIRL on the surface of RBC.
RBCs from a control subject (CTRL) and a patient (PNH) were analyzed for CD55 and CD59 expression as described in Materials and Methods. Note the typical heterogeneous pattern of CD59 staining obtained with
PNH cells compared with the uniformly positive staining of control
RBC.
|
|
Reagents.
Magnetic beads with covalently bound affinity purified sheep antimouse
IgG (Dynabeads M-450*SAM) or antihuman TfR (Dynabeads M-450*CD71) were
from Dynal France S.A. (Compiègne, France). Monoclonal antibodies
(MoAb) against human and rat transferrin receptors were obtained from
Monosan (Uden, The Netherlands) and Chemicon (Temecula, CA),
respectively. Culture supernatants of OKT9 cells (American Type Culture
Collection, Rockville, MD) were used to detect human TfR by Western
blot. MoAbs specific to CD55, CD58, and CD59 antigens were from Cymbus
Biotechnology Ltd (Hants, UK), Chemicon and Monosan, respectively.
Fluorescein isothiocyanate (FITC)-conjugated goat antimouse IgG
(GAM-FITC) and goat antirabbit IgG (GAR-FITC), FITC-conjugated cholera
toxin B subunit (FITC-CTB), and wheat germ agglutinin (FITC-WGA) were
purchased from Sigma (St Louis, MO). Antibodies to rat
acetylcholinesterase16 were a generous gift of Jean
Massoulié (E.N.S., Paris, France). Phosphatidylinositol-specific phospholipase C (PI-PLC) from Bacillus cereus was obtained from Boehringer Mannheim (Meylan, France).
Exosome preparation.
Peripheral blood was collected from phenylhydrazine-treated rats
(Sprague-Dawley) by cardiac puncture as previously
described.17 After removing the buffy coat, RBCs
(reticulocyte count >70%) were washed three times with
phosphate-buffered saline (PBS) and subcultured (3% suspension) for 24 hours at 37°C in maturation medium (RPMI supplemented with 5 mmol/L
glutamine, 5 mmol/L adenosine, 10 mmol/L inosine). After cell
pelleting, the culture supernatant was centrifuged (20,000g for
20 minutes) to remove cellular debris. Exosomes were separated from the
supernatant by centrifugation (100,000g for 90 minutes). The
pellet (vesicular fraction) was washed once by centrifugation and
resuspended in 250 mmol/L sucrose, 10 mmol/L Tris-HCl (pH 7.4).
Venous peripheral blood was drawn from the PNH patient and anemic
controls into EDTA-containing tubes. After centrifugation and two
washes with PBS, the packed cells were resuspended (3%) and
subcultured in maturation medium. Exosomes were collected as described
above.
Immunobinding of exosomes to magnetic beads.
A total of 100 µL of Dynabeads M-450 coupled with SAM (4 × 108 beads/mL) were washed twice with 4 mL of PBS and
resuspended in the same volume. The magnetic beads were then incubated
with 10 µL of MoAbs (antihuman or antirat) TfR overnight at 4°C
with gentle rotation. After three washes in PBS, the beads were
incubated with the different exosome preparations. A total of 100 µL
of exosomes, containing 2 to 5 mg protein/mL, were added for at least 2 hours at 4°C. Exosome-bead complexes, in some cases blocked with
rabbit antimouse IgG, were then washed twice using a magnet, with 4 mL
of PBS containing 1% fetal calf serum (PBS-FCS).
Complexes with various exosome densities on the bead surface were
obtained by incubation of increasing exosome amounts (1, ×5,
×25) with the same number of beads. After coupling, the complexes were analyzed for the presence of CD59 by flow cytometry and for AChE
activity after detergent solubilization. The higher exosome density per
bead corresponded to the conditions used throughout this work and was
thus set arbitrarily at 1. The shift of fluorescence peak was obtained
for each exosome/bead ratio by subtracting the peak position value of
GAM-FITC alone from the fluorescence resulting from CD59 labeling.
Electron microscopy.
Exosome-bead conjugates were fixed in glutaraldehyde 2% for 1 hour at
room temperature. Exosomes immunologically bound to magnetic beads were
fixed in suspension with 2% glutaraldehyde in PBS for 1 hour at room
temperature and then centrifuged for 10 minutes at 13,000g and
postfixed in osmium. The pellet was stained in bloc with magnesium
uranyl acetate, dehydrated in graded ethanol, and embedded in epon.
Sections were stained with uranyl acetate and lead citrate and observed
on a Hitachi 7000-100 electron microscope (Hitachi Scientific
Instruments, Dusseldorf, Germany).
Flow cytometric analysis.
A total of 10 µL of exosome-bead complexes in 100 µL PBS-FCS were
incubated with the different primary antibodies for 30 minutes at room
temperature, washed three times using a magnet with PBS-FCS, and
incubated with corresponding FITC-labeled secondary antibodies for 30 minutes at room temperature. In the indicated experiments, fluorescent
lectins (FITC-WGA and FITC-CTB) were incubated with the exosome-bead
complexes for 1 hour at 37°C. After washing, the samples were
analyzed using an Epics XL flow cytometer (Coulter, Hialeah, FL)
equipped with an ion Argon LASER (488 nm). Beads or exosome-bead
complexes were assessed from the dot plot representation of forward
scatter (size) versus side scatter (granularity), which were set at
logarithmic gain. Only single beads or complexes were gated for
fluorescence analysis (logarithmic scale). Twenty thousand events were
analyzed for each sample.
PI-PLC sensitivity of AChE.
Exosomes (approximately 2 mg protein/mL) were extracted with 1% Triton
X-100, 10 mmol/L Tris/HCl pH 7.4, 1 mmol/L EGTA, 5 mmol/L EDTA, and
proteinase inhibitors (Boehringer Mannheim): aprotinin (2 µg/mL),
leupeptin (0.5 µg/mL), and pepstatin (0.7 µg/mL) for 15 minutes at
4°C with intermittent stirring. After a 15-minute centrifugation at
10,000g, AChE was recovered in the supernatant. This exosome
extract was used as control or treated for 1 hour at 37°C with
PI-PLC (5 U/mL). Nondenaturing polyacrylamide gel electrophoresis was
performed as described previously.18 Briefly, gels and
running buffers contained 50 mmol/L Tris/glycine (pH 8.9) and 0.5%
Triton X-100. Samples (15 µL) were run for 3 hours at 10 V/cm. Gels
were rinsed in distilled water and stained for AChE activity according
to Karnovsky and Roots.19
Sedimentation analyses were performed in 11 mL 5% to 20% linear
sucrose gradients containing 10 mmol/L Tris/HCl (pH 7.4), 150 mmol/L
NaCl, plus or minus 1% Triton X-100. Samples of 190-µL exosome
extracts were loaded and centrifuged for 19 hours at 36,000 rpm and
4°C in a SW41 rotor (200,000g). Fractions were collected from the bottom of each gradient and assayed for AChE at pH 7. One unit
is defined as the amount catalyzing the hydrolysis of 1 µmol
acetylthiocholine substrate/minute at 20°C.18
| |
RESULTS |
Exosomal AChE is anchored through a GPI.
PI-PLC treatment of rat exosomes induced a more mobile form of AChE in
nondenaturing polyacrylamide gel electrophoresis
(Fig 1A). This is typical of partial
conversion of the amphiphilic dimer (G2a) into the hydrophilic dimer
(G2h) form of RBC AChE.18 This was confirmed by sucrose
gradient centrifugation analysis (Fig 1B). Using an untreated detergent
extract of rat exosomes, a single AChE activity peak was obtained,
which sedimented at 6 Svedberg (S) in the presence of 1% Triton X-100.
When the detergent was omitted in the gradient, AChE activity was
recovered as a broad peak around 12 S, indicative of the formation of
micellar aggregates. However, AChE activity sedimented in the same
gradient as a well-defined peak shifted to 6.8 S after incubation of
exosomal detergent extract with PI-PLC. The amount of AChE activity
recovered in this 6.8S peak, typical of the hydrophilic dimer of AChE,
indicated that conversion of amphiphilic AChE by PI-PLC was complete.
Taken together, these results showed that AChE was secreted in the
extracellular medium, associated with the exosome membrane through a
GPI anchor.
View larger version (81K):
[in this window]
[in a new window]
View larger version (20K):
[in this window]
[in a new window]
| Fig 1.
Sensitivity of rat exosomal AChE to PI-PLC. (A)
Nondenaturing gel electrophoresis. Lane a, detergent extract of rat
exosomes; lane b, detergent extract of exosomes treated by PI-PLC as
outlined in Materials and Methods. (B) Sedimentation analysis. Samples of exosomal detergent extracts, treated ( ) or not ( ,  ) by
PI-PLC, were layered on 5% to 20% sucrose gradients containing ()
or not (, ) 1% Triton X-100, and centrifuged for 19 hours at
36,000g. Collected fractions were assayed for AChE activity as
described in Materials and Methods. The vertical arrows indicate the
positions of E coli  -galactosidase (16S) and alkaline
phosphatase (6.1S).
|
|
Exosome-bead complex construction.
Coupling exosomes to beads was dictated by requirement of antibody
binding/washing steps during the immunophenotypic labeling. TfR was
ideally suited to conjugate the exosomes to beads, because of its high
amount on the vesicle surface and specificity as an exosome marker. We
set up the conditions, using highly-available exosomes derived from rat
reticulocytes and magnetic beads coupled with SAM, and a mouse
monoclonal antirat TfR as a secondary antibody. Coupling the two types
of particles was very efficient and homogeneous, as assessed by
electron microscopy (Fig 2A). It also
confirmed the size homogeneity of exosomes (diameter around 60 nm) (Fig 2B). Another effect of coupling, apart from simplifying washing of the
complex, was that the exosomal signal could be distinguished from the
background detection (nonexosomal vesicles, small particles, etc)
during flow cytometry analysis because of the larger size of the beads
(4.5 µm) as compared with exosomes (Fig
3A). As the beads were precisely calibrated, populations that were
double or triple the size of the beads could be detected, probably
because of exosomal cross-linking (Fig 3A). In subsequent experiments, only single beads or complexes were gated for fluorescence analysis. FITC-labeled wheat germ agglutinin (WGA), a lectin binding
N-acetyl-glucosamine-containing glycoproteins and glycoconjugates, was
used as a control to nonspecifically stain the exosome-bead complexes.
The addition of detergent diminished the WGA-FITC labeling of
exosomes-bead complexes to the fluorescent level obtained by WGA-FITC
labeling of anti-TfR antibody-conjugated beads, showing the exosomal
origin of the staining (Fig 3B). Finally, an antirat
acetylcholinesterase16 was used to test the detection potential of the specific antigen on our construction. The complexes were AChE-positive, as shown by a shift in the fluorescence peak (Fig
3C).
View larger version (198K):
[in this window]
[in a new window]
View larger version (145K):
[in this window]
[in a new window]
| Fig 2.
Characterization of rat exosome-bead conjugates by
electron microscopy. Electron micrographs of magnetic beads
immunologically coated with exosomes. Beads were coated with vesicles
of 60 nm average diameter. Most vesicles were filled with
electron-dense material (A) (bar, 1 µm). The beads were uniformly
coated with vesicles, with most of them directly attached to the beads.
Some vesicles appeared to be extracted and partially flattened (B).
|
|
View larger version (18K):
[in this window]
[in a new window]
| Fig 3.
Characteristics of rat exosome-bead conjugates. (A) The
size/structure of exosome-bead conjugates was analyzed using a Coulter Epics XL. The window set as in the left panel allowed visualization of
populations of conjugates with single (s), double (d), and triple (t)
sized beads (right panel). The window was then set to measure only
fluorescence associated with single-bead complexes. (B) Representative
flow cytometric analysis of WGA-FITC labeled exos-beads. Conjugates
were incubated with lectin, washed, and FACS analysis was performed
before (solid line) and after (dotted line) the addition of detergent.
(C) Surface expression of AChE on conjugates (solid line). Background
staining was obtained by labeling the exosome-bead conjugates only with
GAR-FITC (dotted line).
|
|
DAF, MIRL, and LFA-3 are present on the exosome surface.
The presence of three other GPI-anchored proteins, DAF (CD55), MIRL
(CD59), and LFA-3 (CD58) within exosomes was investigated. For this
immunophenotypic analysis, human reticulocytes were incubated in vitro
in maturation conditions, and exosomes released in the medium were
collected and coupled to either SAM-magnetic beads, using mouse MoAb
antihuman TfR or directly to Dynabeads M-450*CD71. As shown in
Fig 4A, exosomes were labeled with
anti-CD55, anti-CD59, and anti-CD58 antibodies. Note that, in the three
cases, the fluorescence peaks were very sharp and markedly shifted as
compared with control (GAM-FITC alone), indicating a very homogenous
phenotype. Staining also showed a negative population only with LFA-3.
By using the cross-reactivity of antirat AChE with the human
protein,16 we analyzed the staining of these human exosomes
for AChE (Fig 4B). As was the case with rat exosomes, the fluorescence
peak obtained was higher than for the other GPI-anchored proteins. Note
also that the fluorescence intensity of GAM-FITC staining was higher than with GAR-FITC alone, probably due to the labeling of anti-TfR mouse antibody on the magnetic bead surface.
View larger version (18K):
[in this window]
[in a new window]
| Fig 4.
Flow cytometric analysis of DAF, MIRL, LFA-3, and AChE
expression on human exosome-bead conjugates. Staining for
DAF/MIRL/LFA-3 (A) and AChE (B) was performed as detailed in Materials
and Methods. Labeling only with the respective FITC-conjugated anti-IgG
was used as background staining. Typical labeling patterns obtained from the same preparation of exosome-bead conjugates are presented.
|
|
Sorting of DAF and MIRL is very efficient in exosomes.
We used blood from PNH patients to further analyze the sorting of these
GPI-anchored molecules in exosomes. Figure
5 shows the results of the flow cytometry analysis of DAF and MIRL on the surface of RBCs from a PNH (case 1) and a control patient. As
compared with normal RBC, which had uniform, positive staining with
anti-CD59, there was high heterogeneity of MIRL expression in RBC of
this PNH patient. Approximately 40% of the circulating RBCs showed
negative expression (type III), around 50% showed intermediate
expression (type II), and 10% showed normal expression (type I).
Interestingly, the deficiency of DAF expression was less marked than
for the other GPI-anchored protein. RBCs from this PNH patient and from
an anemic patient (reticulocyte count, 12.5% and 6%, respectively)
were cultured in vitro, and the released vesicles were analyzed for the
presence of TfR by Western blot. As shown in
Fig 6, the amount of TfR associated with
exosomes was very similar. As previously described,2,20 the
dimeric form of TfR could be detected, even after electrophoresis in
reducing conditions. Similarly, a lower molecular weight band was
observed, probably resulting from TfR proteolysis.21,22
Moreover, the protein and phospholipid (PL) contents of the released
vesicles were similar (4.5 mg protein/mL and 1.2 mmol/L PL v
5.4 mg protein/mL and 1 mmol/L PL, for the PNH patient v
control, respectively). In contrast, as expected, AChE activity was
reduced (fivefold) in exosomes collected from PNH cells (0.028 U/mg
protein v 0.147 U/mg protein). When analyzed by flow cytometry,
this low-AChE phenotype was observed with PNH exosomes as compared with
exosomes from control patients (Fig 7).
Surprisingly, expression of other GPI-anchored proteins on the surface
of exosomes from PNH or control patients was very similar (DAF) or
identical (MIRL). To further analyze these results, we performed a
dose-response experiment using increasing exosome/bead ratios during
the coupling reaction. The amount of exosomes bound was quantified
biochemically using AChE activity and found to correspond perfectly to
the ratios used for the coupling reaction
(Fig 8). When the complexes were analyzed
by flow cytometry labeling with anti-CD59, increasing amounts of CD59
(shift of fluorescence peak) were detected with higher exosome/bead
ratios, although the relationship between these ratios and the
fluorescence peak shift was not linear.
View larger version (21K):
[in this window]
[in a new window]
| Fig 6.
Immunodetection of TfR in exosomes released from control
and PNH reticulocytes. Samples (50 µg protein) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in
a 10% acrylamide gel and proteins were transferred to nitrocellulose. TfR was detected by Western blot using a MoAb (OKT9) raised against human TfR and an alkaline phosphatase-conjugated rabbit antimouse antibody. The molecular mass (kD) standards are indicated
on the right.
|
|
View larger version (26K):
[in this window]
[in a new window]
| Fig 7.
Comparison of GPI-anchored protein (AChE, DAF, MIRL)
expression onto control and PNH exosomes. Exosomes released from
reticulocytes of a control subject (CTRL) and a patient (PNH) were
analyzed, as described in Materials and Methods, for the presence of
the different GPI-anchored proteins. Background staining obtained with
only the FITC-labeled antibodies are presented.
|
|
View larger version (18K):
[in this window]
[in a new window]
| Fig 8.
Relationship between fluorescence peak shift and antigen
densities on bead surface. Complexes with various exosome amounts on
the bead surface were obtained as described in Materials and Methods
and analyzed for CD59 expression by flow cytometry () and AChE
activity ( ).
|
|
GM1 is present in rat reticulocyte exosomes.
GM1 is not present in human RBCs, but is found in rat
erythrocytes.23 We thus analyzed the binding of
FITC-conjugated cholera toxin B subunit to exosomes. Vesicles from
human or rat reticulocytes were labeled with increasing amounts of
FITC-CTB (Fig 9). The shift in the
fluorescence peak was plotted as a function of the amount of added
FITC-CTB. As expected, human exosomes used as negative control did not
bind significant amounts of FITC-CTB. Conversely, a clear titration
curve was obtained with rat exosomes. GM1 was thus released in rat
reticulocyte exosomes, together with the TfR and GPI-anchored proteins.
View larger version (18K):
[in this window]
[in a new window]
| Fig 9.
Binding of FITC-CTB on rat reticulocyte exosomes.
Exosomes from rat () or human () reticulocytes were conjugated to
magnetic beads. Increasing amounts of the FITC-CTB were incubated with 100 µL of exosome-bead conjugates and analyzed by flow cytometry as
described in Materials and Methods. The fluorescence peak position is
plotted as a function of added FITC-CTB.
|
|
| |
DISCUSSION |
Exosomes are mainly known as vesicles involved in the clearance of
obsolete proteins from the erythrocyte surface, such as the TfR. Other
transmembrane proteins are also sorted in these vesicles, but the
molecule sorting mechanism is still unknown. We have shown that the
sorting step could involve parameters such as the aggregation state of
molecules on the membrane surface, and also the nature of lipid
components of the bilayer. Indeed, we showed that molecule (TfR, AChE)
aggregation reroutes molecules towards exosomal release, instead of
recycling to the plasma membrane.2 Moreover, N-(lissamine
rhodamine B sulfonyl) phosphatidyl ethanolamine (N-Rh-PE), after
insertion into the plasma membrane of reticulocytes, was shown to be
selectively sorted from other lipid and accumulated in exosomes. We
proposed that such sorting is triggered by the presence of the
fluorescent analog in the membrane as small molecular clusters. As
natural lipids such as glycosphingolipids are also able to interact by
hydrogen bonding, the fate of N-Rh-PE in reticulocytes may represent
amplification of the physiologic route of specific membrane
lipids.24 Moreover, glycosphingolipids are known to be
molecular partners of lipid domains found in the trans-Golgi network or
caveolae,6,7 where proteins are specifically sorted. It has
been shown that GPI-anchored proteins are enriched in these domains.7 AChE is sorted in exosomes and as shown here,
sensitive to PI-PLC treatment, demonstrating its GPI-anchoring to the
exosomal membrane. We propose that the GPI-anchor could be a sorting
signal for AChE, and thus that other GPI-anchored proteins must also be
sorted in reticulocyte exosomes.
The presence of three other GPI-anchored proteins (DAF, MIRL, and
LFA-3) in exosomes is shown here. This indicates involvement of the
GPI-anchor during the intracellular sorting step of exosomal vesicles.
This was further shown in experiments using exosomes collected from PNH
patients. In this disease, GPI-anchored proteins are almost or
completely missing from the cell surface because of a defect in the
biosynthesis of the GPI-anchor.11 The well established
heterogeneity in GPI-anchored protein expression in cells of PNH
patients was also noted here, as RBC of these patients showed very
deficient MIRL (CD59) expression, while being closer to normal in DAF
(CD55). We confirmed the clinical phenotypic analysis through
quantitation of AChE released in exosomes from reticulocytes by two
independent methods, namely AChE activity and flow cytometry
immunodetection. Note that, depending on the quantitation method used,
the extent of the AChE decrease in PNH versus control exosomes
differed. This was confirmed by a dose-response curve using various
amounts of exosomes coupled per bead, showing that the relationship
between the antigen density and the fluorescence peak shift obtained
with the fluorescence-activated cell sorting (FACS)-based methodology
was not linear. However, as in the case of AChE (Fig 7, upper panel), a
fivefold decrease in CD59 was detectable by immunolabeling.
Complexes were then stained for DAF and MIRL. The results were very
similar or identical, respectively, when comparing normal exosomes with
PNH exosomes. Although the methodology is not completely quantitative,
it nevertheless clearly shows that the densities of GPI-anchored
proteins were much higher on the exosome membrane than on the cell
surface. Although only 10% of PNH RBCs showed normal expression (type
I), while 40% were negative (type III), especially for CD59, the final
expression on the exosomal surface was identical between PNH and
control complexes (Fig 7, lower panel). We conclude from these results
that sorting of GPI-anchored proteins in exosomes is a very efficient
mechanism.
This also means that, during reticulocyte maturation, the release of
exosomes contributes to the loss of a certain amount of GPI-anchored
proteins. This exosomal loss may account for the previously noted
paradox15 between percentages of type II reticulocytes and
type II mature erythrocytes. Indeed, type II erythrocytes (ie,
partially CD59-deficient) were often found in PNH patients with
virtually no type II reticulocytes. In our data, type II erythrocytes
could thus have been derived, at least partly, from the maturation of
type I reticulocytes. This is also in agreement with a very recent
study suggesting that disappearance of PNH II erythroblasts during
maturation to erythrocytes is related to other mechanisms in addition
to hypersensitivity to the complement.25
These results highlight the efficiency of GPI-anchored protein sorting
during exosome formation. In other words, the little that is expressed
as GPI-anchored proteins on the reticulocyte surface is very
efficiently sorted during reticulocyte maturation. This is in agreement
with the presence, in rat exosomes, of GM1, a ganglioside that is found
in high quantities in caveolae.8 In fact, the efficiency of
sorting on membrane surface might reflect a cause of the exosome
formation rather than a consequence. Indeed, enrichment of GPI-anchored
proteins could be expected to participate in the budding phenomenon.
Considerable evidence favors this hypothesis: (1) coat proteins have
not been described in exosomes, suggesting that some membrane
components may be involved, (2) RBCs from PNH patients cannot properly
vesiculate when submitted to Ca2+ ionophore
A23187,26 (3) the membrane (and budding) topology is
identical in these cases (exosome formation and calcium-induced plasma
membrane shedding) but, contrary to caveolae formation, which requires
the involvement of the protein caveolin not found here,27
(4) similar vesicles released by other cells, such as prostasomes
derived from prostate epithelial cells, are enriched with GPI-anchored
proteins (CD59)28, (5) exosomes derived from B lymphocytes
were shown to be devoid of TfR, but contain LFA-3 (CD58).29
GPI-anchored proteins may contribute to exosome formation suggesting a
new vesicle function. Exosomes from reticulocytes could participate in
complement regulation, acting directly with complement proteins through
DAF and MIRL, or by representing a circulating reservoir of
GPI-anchored proteins that could transfer from the exosomal membrane to
plasma membrane of cells. GPI-anchored proteins can be transferred
directly from the plasma membrane of RBCs to endothelial
cells.30,31 It is thus possible that transfer of DAF and
MIRL to these target membranes is facilitated by the high curvature of
the exosome membrane as compared with the plasma membrane. Here it
should be noted that integrin  41 is downregulated during normal
erythroid differentiation,32 but expressed on circulating
reticulocytes in sickle cell anemia.33 It is thus possible
that exosomes express 41, which may be involved in GPI-anchored
protein transfer through interaction with vascular cell adhesion
molecule-1 (VCAM-1) present on the surface of endothelial cells.
Indeed, it was shown with prostasomes that a close apposition between
the vesicle and plasma membrane is a prerequisite for GPI-protein
transfer.34 Experiments are currently under way to assess
the possibility of a molecular transfer of GPI-anchored proteins,
especially DAF and MIRL, from exosomes to target cell membranes.
Finally, note that some viruses have been found to bud from major
histocompatability complex (MHC) class II compartments
(MIICs) in B lymphocytes, and to be released as exosome-like virions
(G. Raposo, personal communication, July 1996). MIICs are similar to
reticulocyte multivesicular endosomes in terms of several
characteristics.35 This may be a way by which viruses
incorporate CD55 and CD59 onto their envelope and escape inactivation
by human complement.36
| |
FOOTNOTES |
Submitted May 12, 1997;
accepted November 14, 1997.
Supported by the Centre National de la Recherche Scientifique and by
grants from the Université Montpellier II and the Hôpital St Eloi.
Address reprint requests to Michel Vidal, PhD, UMR 5539, Univ. Montpellier II, cc107, Montpellier 34095, France.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" is accordance with 18 U.S.C. section 1734 solely to indicate this fact.
| |
REFERENCES |
1.
Johnstone RM,
Adam M,
Hammond JR,
Orr L,
Turbide C:
Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).
J Biol Chem
262:9412,
1987[Abstract/Free Full Text]
2.
Vidal M,
Mangeat P,
Hoekstra D:
Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation.
J Cell Sci
110:1867,
1997[Abstract/Free Full Text]
3.
Low MG,
Finean JB:
Non-lytic releasqe of acetylcholinesterase from erythrocytes by a phosphatidylinositol-specific phospholipase C.
FEBS Lett
82:143,
1977[Medline]
[Order article via Infotrieve]
4.
Haas R,
Brandt PT,
Knight J,
Rosenberry TL:
Identification of amine components in a glycolipid membrane-binding domain at the C-terminus of human erythrocyte acetylcholinesterase.
Biochemistry
25:3098,
1986[Medline]
[Order article via Infotrieve]
5.
Davis JQ,
Dansereau D,
Johnstone RM,
Bennett V:
Selective externalization of an ATP-binding protein structurally related to the clathrin-uncoating ATPase/heat shock protein in vesicles containing terminal transferrin receptors during reticulocyte maturation.
J Biol Chem
261:15368,
1986[Abstract/Free Full Text]
6.
Simons K,
Wandinger-Ness A:
Polarized sorting in epithelia.
Cell
62:207,
1990[Medline]
[Order article via Infotrieve]
7.
Anderson RGW:
Plasmalemmal caveolae and GPI-anchored membrane proteins.
Curr Opin Cell Biol
5:647,
1993[Medline]
[Order article via Infotrieve]
8.
Schnitzer JE,
McIntosh DP,
Dvorak AM,
Liu J,
Oh P:
Separation of caveolae from associated microdomains of GPI-anchored proteins.
Science
269:1435,
1995[Medline]
[Order article via Infotrieve]
9.
Kinoshita T,
Medof ME,
Nussenzweig V:
Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.
J Immunol
136:3390,
1986[Abstract/Free Full Text]
10.
Rollins SA,
Zhao J,
Ninomiya H,
Sims PJ:
Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
J Immunol
146:2345,
1991[Abstract/Free Full Text]
11.
Rosse WF,
Ware RE:
The molecular basis of paroxysmal nocturnal hemoglobinuria.
Blood
9:3277,
1995
12.
Takeda J,
Miyata T,
Kawagoe K,
Iida Y,
Endo Y,
Fujita T,
Takahashi M,
Kitani T,
Kinoshita T:
Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.
Cell
73:703,
1993[Medline]
[Order article via Infotrieve]
13.
Iwamoto N,
Kawaguchi T,
Nagakura S,
Hidaka M,
Horikawa K,
Kagimoto T,
Takatsuki K,
Nakakuma H:
Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
Blood
85:2228,
1995[Abstract/Free Full Text]
14.
Shichishima T,
Terasawa T,
Hashimoto C,
Ohto H,
Takahashi M,
Shibata A,
Maruyama Y:
Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Blood
81:1855,
1993[Abstract]
15.
Ware RE,
Rosse WF,
Hall SE:
Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria.
Blood
86:1586,
1995[Abstract/Free Full Text]
16.
Marsh D,
Grassi J,
Vigny M,
Massoulié J:
An immunological study of rat acetylcholinesterase: Comparison with acetylcholinesterase from other vertebrates.
J Neurochem
43:204,
1984[Abstract]
17.
Vidal M,
Hoekstra D:
In vitro fusion of reticulocyte endocytic vesicles with liposomes.
J Biol Chem
270:17823,
1995[Abstract/Free Full Text]
18.
Toutant JP,
Richards MK,
Krall JA,
Rposenberry TL:
Molecular forms of acetylcholinesterase in two sublines of human erythroleukemia K562 cells. Sensitivity or resistance to phosphatidylinositol-specific phospholipase C and biosynthesis.
Eur J Biochem
187:31,
1990[Abstract]
19.
Karnovsky MJ,
Roots L:
A direct-coloring thiocholine method for cholinesterases.
J Histochem Cytochem
12:219,
1964
20.
Ahn J,
Johnstone RM:
Origin of a soluble truncated transferrin recptor.
Blood
81:2442,
1993[Abstract]
21.
Vidal MJ,
Stahl PD:
The small GTP-binding proteins Rab4 and ARF are associated with vesicles released during reticulocyte maturation.
Eur J Cell Biol
60:261,
1993[Medline]
[Order article via Infotrieve]
22. Johnstone RM: Cleavage of the transferrin receptor by human
granulocytes: Preferential proteolysis of the exosome-bound TfR. J Cell
Physiol 168:333,1996
23.
Iwamori M,
Shimomura J,
Nagai Y:
Specific binding of cholera toxin to rat erythrocytes revealed by analysis with a fluorescence-activated cell sorter.
J Biochem
97:729,
1985[Abstract]
24.
Sandhoff K,
Klein A:
Intracellular trafficking of glycosphingolipids: Role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion.
FEBS Lett
346:103,
1994[Medline]
[Order article via Infotrieve]
25.
Shichishima T,
Saitoh Y,
Terasawa T:
Relationship between the phenotypes of circulating erythrocytes and cultured erythroblasts in paroxysmal nocturnal hemoglobinuria.
Blood
90:435,
1997[Abstract/Free Full Text]
26.
Whitlow M,
Iida K,
Marshall P,
Silber R,
Nussenzweig V:
Cells lacking glycan phosphatidylinositol-linked proteins have impaired ability to vesiculate.
Blood
81:510,
1993[Abstract]
27.
Rothberg KG,
Heuser JE,
Donzell WC,
Ying YS,
Glenney JR,
Anderson RGW:
Caveolin, a protein component of caveolae membrane coats.
Cell
68:673,
1992[Medline]
[Order article via Infotrieve]
28.
Rooney IA,
Atkinson JP,
Krul ES,
Schonfeld G,
Polaloski K,
Saffitz JE,
Morgan BP:
Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis.
J Exp Med
177:1409,
1993[Abstract]
29.
Raposo G,
Nijman HW,
Stoorvogel W,
Leidendekker R,
Harding CV,
Meleif CJM,
Geuze H:
B lymphocytes secrete antigen-presenting vesicles.
J Exp Med
183:1,
1996[Medline]
[Order article via Infotrieve]
30.
Kooyman DL,
Byrne GW,
McClellan S,
Nielsen D,
Tone M,
Waldmann H,
Coffman TM,
McCurry KR,
Platt JL,
Logan JS:
In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium.
Science
269:89,
1995[Medline]
[Order article via Infotrieve]
31.
McCurry KR,
Kooyman DL,
Alvarado CG,
Cotterell AH,
Martin MJ,
Logan JS,
Platt JL:
Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury.
Nat Med
1:423,
1995[Medline]
[Order article via Infotrieve]
32.
Coulombel L,
Auffray I,
Gaugler MH,
Rosemblatt M:
Expression and function of integrins on hematopoietic progenitor cells.
Acta Haematol
97:13,
1997[Medline]
[Order article via Infotrieve]
33.
Joneckis CC,
Ackley RL,
Orringer EP,
Wayner EA,
Parise LV:
Integrin 41 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia.
Blood
82:3548,
1993[Abstract]
34.
Rooney IA,
Heuser JE,
Atkinson JP:
GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical conditions and the mechanisms of their binding to exogenous cells.
J Clin Invest
97:1675,
1996[Abstract/Free Full Text]
35. Raposo G, Vidal M, Geuze H: Secretory lysosomes and the
production of exosomes, in Kuchler K, Rubartelli A, Holland B (eds):
Unusual Secretory Pathways: From Bacteria to Man. New York, NY,
Springer-Landes Bioscience, 1997, p161
36.
Marschang P,
Sodroski J,
Würnzer R,
Dierich MP:
Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement.
Eur J Immunol
25:285,
1995[Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
E. M. Pasini, M. Kirkegaard, D. Salerno, P. Mortensen, M. Mann, and A. W. Thomas
Deep Coverage Mouse Red Blood Cell Proteome: A First Comparison with the Human Red Blood Cell
Mol. Cell. Proteomics,
July 1, 2008;
7(7):
1317 - 1330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Calzolari, C. Raggi, S. Deaglio, N. M. Sposi, M. Stafsnes, K. Fecchi, I. Parolini, F. Malavasi, C. Peschle, M. Sargiacomo, et al.
TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway
J. Cell Sci.,
November 1, 2006;
119(21):
4486 - 4498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Pasini, M. Kirkegaard, P. Mortensen, H. U. Lutz, A. W. Thomas, and M. Mann
In-depth analysis of the membrane and cytosolic proteome of red blood cells
Blood,
August 1, 2006;
108(3):
791 - 801.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. van Niel, I. Porto-Carreiro, S. Simoes, and G. Raposo
Exosomes: a common pathway for a specialized function.
J. Biochem.,
July 1, 2006;
140(1):
13 - 21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kolegraff, P. Bostik, and A. A. Ansari
Characterization and role of lentivirus-associated host proteins.
Experimental Biology and Medicine,
March 1, 2006;
231(3):
252 - 263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Koury, S. T. Koury, P. Kopsombut, and M. C. Bondurant
In vitro maturation of nascent reticulocytes to erythrocytes
Blood,
March 1, 2005;
105(5):
2168 - 2174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Fevrier, D. Vilette, F. Archer, D. Loew, W. Faigle, M. Vidal, H. Laude, and G. Raposo
Cells release prions in association with exosomes
PNAS,
June 29, 2004;
101(26):
9683 - 9688.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. de Gassart, C. Geminard, B. Fevrier, G. Raposo, and M. Vidal
Lipid raft-associated protein sorting in exosomes
Blood,
December 15, 2003;
102(13):
4336 - 4344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. PATTANAPANYASAT, D. S. WALSH, K. YONGVANITCHIT, N. PIYAWATTHANASAKUL, W. WANACHIWANAWIN, and H. K. WEBSTER
ROBUST IN VITRO REPLICATION OF PLASMODIUM FALCIPARUM IN GLYCOSYL-PHOSPHATIDYLINOSITOL-ANCHORED MEMBRANE GLYCOPROTEIN-DEFICIENT RED BLOOD CELLS
Am J Trop Med Hyg,
October 1, 2003;
69(4):
360 - 365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Gould, A. M. Booth, and J. E. K. Hildreth
The Trojan exosome hypothesis
PNAS,
September 16, 2003;
100(19):
10592 - 10597.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Mortazavi, B. Merk, J. McIntosh, J. C. W. Marsh, H. Schrezenmeier, and T. R. Rutherford
The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot
Blood,
April 1, 2003;
101(7):
2833 - 2841.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Wubbolts, R. S. Leckie, P. T. M. Veenhuizen, G. Schwarzmann, W. Mobius, J. Hoernschemeyer, J.-W. Slot, H. J. Geuze, and W. Stoorvogel
Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes. POTENTIAL IMPLICATIONS FOR THEIR FUNCTION AND MULTIVESICULAR BODY FORMATION
J. Biol. Chem.,
March 21, 2003;
278(13):
10963 - 10972.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Fritzsching, B. Schwer, J. Kartenbeck, A. Pedal, V. Horejsi, and M. Ott
Release and Intercellular Transfer of Cell Surface CD81 Via Microparticles
J. Immunol.,
November 15, 2002;
169(10):
5531 - 5537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Kai, T. Shichishima, H. Noji, T. Yamamoto, M. Okamoto, K. Ikeda, and Y. Maruyama
Phenotypes and phosphatidylinositol glycan-class A gene abnormalities during cell differentiation and maturation from precursor cells to mature granulocytes in patients with paroxysmal nocturnal hemoglobinuria
Blood,
November 15, 2002;
100(10):
3812 - 3818.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Valdez, W. Mah, M. M. Winslow, L. Xu, P. Ling, and S. E. Townsend
Major Histocompatibility Complex Class II Presentation of Cell-associated Antigen Is Mediated by CD8{alpha}+ Dendritic Cells In Vivo
J. Exp. Med.,
March 11, 2002;
195(6):
683 - 694.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. N. Waitumbi, M. O. Opollo, R. O. Muga, A. O. Misore, and J. A. Stoute
Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia
Blood,
February 15, 2000;
95(4):
1481 - 1486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Denzer, M. Kleijmeer, H. Heijnen, W Stoorvogel, and H. Geuze
Exosome: from internal vesicle of the multivesicular body to intercellular signaling device
J. Cell Sci.,
January 10, 2000;
113(19):
3365 - 3374.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Hugel, G. Socie, T. Vu, F. Toti, E. Gluckman, J.-M. Freyssinet, and M.-L. Scrobohaci
Elevated Levels of Circulating Procoagulant Microparticles in Patients With Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia
Blood,
May 15, 1999;
93(10):
3451 - 3456.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Geminard, F. Nault, R. M. Johnstone, and M. Vidal
Characteristics of the Interaction between Hsc70 and the Transferrin Receptor in Exosomes Released during Reticulocyte Maturation
J. Biol. Chem.,
March 23, 2001;
276(13):
9910 - 9916.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Abstract
Introduction
Abstract